LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radiation plus immunotherapy shows promise for advanced liver cancer
Disease control Recruiting nowThis study tests if adding immunotherapy drugs (atezolizumab and bevacizumab) after targeted radiation therapy (SIRT-Y90) works better than radiation alone for people with advanced liver cancer that hasn't spread outside the liver. About 100 participants will be randomly assigned…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated May 26, 2026 06:48 UTC
-
New hope for liver cancer: combo therapy tested after first treatment fails
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (atezolizumab) to a standard targeted therapy (cabozantinib or lenvatinib) works better than the targeted therapy alone for people with advanced liver cancer that cannot be surgically removed and has already been treated with …
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors (like breast, lung, or skin cancer). The goal is to see if the combination is safe and helps the immune syst…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Could less be more? new study tests lower cancer drug doses to cut side effects
Disease control Recruiting nowThis study tests whether giving a lower, less frequent dose of the cancer drug atezolizumab can still control tumors while causing fewer side effects. About 30 adults with advanced lung, liver, skin, or sarcoma cancers will receive the drug alone or with other treatments. Researc…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Could a common drug help cancer patients regain appetite and weight?
Symptom relief Recruiting nowThis study tests whether olanzapine, a drug that affects brain chemicals, can help people with advanced cancer who are losing weight and appetite. About 66 adults with certain cancers (like lung, stomach, or colon) will receive either olanzapine or a placebo. The goal is to see i…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated May 26, 2026 06:48 UTC